Yesterday, the Indiana Court of Appeals issued a decision dealing with varied theories of estoppel in the context of a legal malpractice case in
, ___ N.E.2d ___ (Ind. Ct. App. 2011), Cause No. 45A04-1007-CT-467. In its decision, the Court held that the trial court erred in granting summary judgment to the defendant through application of judicial estoppel, but that it also couldn't grant summary judgment to the plaintiff because of collateral estoppel. The Court's discussion of each of these issues is enlightening.
less..
In this case, Mr. and Mrs. Price were clients of Kuchaes, who brought a suit in state court on their behalf, claiming that Mrs. Price had contracted polio from a child who had recently been vaccinated. The defendant informed Kuchaes that he should really be pursuing the claim under the National Childhood Vaccine Injury Act. Kuchaes dismissed the complaint and pursued a claim under that Act.
Eventually, Kuchaes learned that Mr. Price's derivative claim was not compensable under the Vaccine Act, so his claim was dismissed and Kuchaes attempted to reinstate the state-court claim. The defendants removed the case to federal court and granted summary judgment to the defendants because the two-year statute of limitations had expired during the intervening years between the voluntary dismissal and the reinstatement of the lawsuit.
In May 2006, Mr. Price filed a legal malpractice action against Kuchaes, alleging that he suffered monetary damages as a proximate result of Kuchaes's failure to timely pursue the loss of consortium claim against the vaccine defendants. In April 2007, the Prices filed for bankruptcy, but did not include either the malpractice action against Kuchaes as a potential asset. After Mr. Price and Kuchaes filed cross-motions for summary judgment, the Prices amended their bankruptcy schedules to include the malpractice action. A month later, the bankruptcy court announced an agreement regarding that action between the Prices and the bankruptcy trustee and found that the creditors' rights were not adversely affected by the agreement. After this happened, the trial court held a hearing on the cross-motions for summary judgment and granted Kuchaes's fully dispositive motion.
On appeal, the Court first addressed whether Mr. Price had standing to bring his claim, because it had not been abandoned by the bankruptcy trustee. The Court held that he did have standing because the Prices' bankruptcy was dismissed, rather than completed. The Court then turned to the question of whether Mr. Price's claim should be barred by application of the doctrine of judicial estoppel.
The Court noted that equitable judicial estoppel is designed to prevent litigants from playing "fast and loose" with the courts, so it prevents litigants from "gain[ing] an advantage by litigating on one theory and then pursue an incompatible theory in subsequent litigation." The Court held that the doctrine should not apply in these circumstances.
The bankruptcy court in its February 2009 order effectively determined that Price's nondisclosure of the malpractice action was cured by his later disclosure of it, allowing the bankruptcy to proceed with the trustee's knowledge and ownership of the claim. ... In addition, and akin to the facts in
Shewmaker, the dismissal of Price's bankruptcy in July 2009 had the effect of returning ownership of the malpractice action from the bankruptcy estate to Price. From then onward, Price's initial nondisclosure was a moot point because there was no longer any obligation for the claim to be scheduled for the benefit of creditors. In these circumstances, we cannot perceive how allowing Price's malpractice action to continue would permit him to play fast and loose with the courts, that is, to prevail twice or otherwise gain an unfair advantage in litigating upon inconsistent theories.
Further, "judicial estoppel is an equitable doctrine." We and other courts have recognized that it is not equitable to apply the doctrine in a manner that harms creditors of the plaintiff who would ultimately benefit from the plaintiff's ability to pay them should the plaintiff recover in his or her malpractice or other injury action. .. Here by contrast, because Price's bankruptcy was dismissed, his debts have not been discharged and any recovery Price may obtain in this malpractice action could inure to the benefit of his creditors. Conversely, applying judicial estoppel against Price in this case could have negative consequences for Price's creditors by denying them an opportunity to recoup their losses should Price prevail in this action.
We also point out that Kuchaes neither alleges nor shows he relied upon or was prejudiced by Price's failure to timely disclose the malpractice action in his bankruptcy. Rather, from Kuchaes's perspective, Price's bankruptcy and the malpractice action were wholly unrelated litigation. As we have observed, judicial estoppel "is not meant to be a technical defense for litigants seeking to derail potentially meritorious claims." And in these circumstances, equitable estoppel is inapplicable.
Thus, the trial court erred when it granted summary judgment to Kuchaes.
The Court then turned to the question of whether the trial court erred when denying Mr. Price's motion for summary judgment. Mr. Price tried arguing that the issue of whether the vaccine defendants manufactured a defective product had been conclusively demonstrated in a Missouri case,
Strong v. Am. Cyanamid Co., 261 S.W.3d 493 (Mo. Ct. App. 2007). The
Strong court affirmed a jury verdict against the same manufacturer by concluding the plaintiff presented sufficient evidence to support a finding, under Missouri law, that the polio vaccine was defective for failure to perform proper testing and such failure proximately caused the plaintiff's vaccine injury. The Court held that it could not give preclusive effect to the
Strong case.
[T]he Strong court applied Missouri's products liability law, not Indiana law. The facts that Price seeks to establish through the Strong case involve the complex lineage of the virus strains allegedly used to produce all of the American Cyanamid polio vaccine after a certain date, inclusive of both the vaccine that injured the Strong plaintiff and the vaccine that injured Cathy. Price thus appears to contend that the same evidence the Strong court accepted as showing the virus strains were not properly tested also establishes a lack of proper testing as to the vaccine that ultimately injured Cathy. However, the form and content of Price's thirty-four-page motion shows that such a contention, if true, can be inferred only by argument and was not expressly adjudicated in Strong. Therefore, collateral estoppel does not apply and the trial court erred in granting Price's motion to accept Strong as preclusive.
Given the evidence, the Court concluded that there were genuine issues of material fact that precluded summary judgment.
The Court's decision in this case demonstrates the difficulty in proving that a trial court can avoid dealing with the merits of a lawsuit through the application of some form of estoppel. In order to demonstrate that a court should apply judicial estoppel, a party must demonstrate that its opponent will gain an unfair advantage and that doing so will prejudice the advocate of applying the doctrine. In order to establish collateral estoppel, you must prove that a fact or legal issue was necessarily adjudicated in the prior case. If your proof on either of these doctrines is insufficient, then you will not obtain the benefits of those doctrines.
